查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986687

快速檢測市場規模、佔有率和趨勢分析報告：按產品、技術、應用、最終用途、地區和細分市場分類，預測期為 2026 年至 2033 年

Rapid Tests Market Size, Share & Trends Analysis Report By Product (Instruments, Consumables), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End Use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10個工作天內

價格

快速檢測市場概述

全球快速檢測市場預計到 2025 年將達到 16.9 億美元，預計到 2033 年將達到 32.5 億美元，2026 年至 2033 年的複合年成長率為 8.30%。

人們認為，這種成長是由於老年人口增加、目標疾病負擔加重以及自我檢測和照護現場產品的使用日益普及所致。

上呼吸道感染疾病（URI）在世界範圍內極為常見，最近的全球估計顯示，其發病率超過每 10 萬人 162,000 例，這凸顯了在臨床環境中快速區分病毒和細菌病因的必要性。

2025年，上呼吸道感染疾病（URTI）仍然是全球主要的健康問題之一，5歲以下兒童和患有潛在疾病的成年人的發生率尤其高。 5歲以下兒童是上呼吸道感染最易感族群，97%的兒童呼吸道合胞病毒（RSV）相關死亡病例發生在低收入和中等收入國家。

此外，呼吸道融合細胞病毒（RSV）是一種高發生病毒感染疾病，尤其容易感染嬰幼兒和老年人。據估計，全球每年約有3,300萬感染疾病由RSV引起，其中超過300萬例需要住院治療。在美國，RSV每年導致5歲以下兒童5.8萬至8萬例住院病例和100至300例死亡病例，以及65歲及以上成人6萬至16萬例住院病例和6000至1萬例死亡病例。 RSV的季節性爆發通常發生在秋冬季，對醫療系統造成重大影響，凸顯了有效診斷和預防措施的迫切需求。

以下是截至 2025 年 1 月 7 日，北半球各國向 FluNet 報告的 2017 年 10 月 1 日至 2024 年 12 月 30 日期間按亞型分類的病毒檢測數量比較：

此資料集顯示了全球範圍內進行的快速診斷測試的估計數量，與觀察到的呼吸道病原體活動相對應：

由於流感季節性高發生且快速免疫診斷測試（RIDT）廣泛普及，快速流感檢測的需求在所有呼吸道檢測中佔比最大。這將推動快速流感診斷測試市場在預測期內實現高速成長。

由於需要對兒童和高風險族群進行篩檢，對快速呼吸道合胞病毒 (RSV) 檢測的需求顯著增加。

hMPV 佔據了雖小但​​重要的市場佔有率，尤其是在專門針對 hMPV 的多重檢測平台中。

這些因素共同表明，呼吸道疾病的季節性趨勢如何反映在診斷需求中，突顯了季節性和病原體特異性檢測的使用，這構成了市場擴張的基礎。

快速檢測在感染疾病監測和整體發揮日益重要的策略作用。到2025年，世界各國政府和衛生部門正在擴大快速診斷試劑盒的覆蓋範圍，以應對除新冠肺炎以外的其他地方性疾病。例如，印度醫學研究理事會（ICMR）正在倡導在基層醫療中心提供乙型肝炎、鐮狀貧血和梅毒等疾病的快速檢測，旨在改善服務不足地區的早期診斷。同時，隨著季節性流感和呼吸道疾病在全球持續蔓延，某些快速檢測（例如快速流感診斷試劑盒（RIDT））的市場預計將穩定成長。目標疾病範圍的擴大意味著快速診斷的應用範圍正在從上呼吸道感染疾病和敗血症的篩檢擴展到感染疾病和非傳染性疾病。

創新和競爭格局正在重塑競爭格局和產品開發軌跡。各公司正日益整合人工智慧、機器學習和微流體等先進技術，以提高檢測靈敏度、實現多參數同步測量並簡化操作，從而加速其在臨床和家庭環境中的應用。現有診斷公司和新參與企業也在影響市場的成長路徑。例如，亞馬遜計劃於2025年中期進軍印度主要城市，提供家庭診斷服務，這顯著改變了投資者對診斷行業的信心。同時，諸如雅培計劃收購Exact Sciences（一家廣泛使用的癌症和基因檢測製造商）等大規模戰略舉措表明，診斷公司正在將其業務從傳統的快速感染疾病檢測擴展到更廣泛的篩檢產品線，同時在競爭日益激烈的市場中平衡品質保證和監管方面的挑戰。

此外，羅氏診斷的「cobas infinity point-of-care」等行動應用程式的推出，將滿足POC協調員的需求，並使他們能夠隨時隨地透過智慧型手機完成任務，從而提高工作效率，預計這將在預測期內加速POC分子診斷產品的普及。

近年來，主要企業紛紛致力於將家用自測產品商業化，新冠疫情進一步加速了這個趨勢。在政府實施封鎖措施期間，這些產品既滿足了臨床需求，也促進了居家隔離。例如，雅培公司銷售的「BinaxNOW Card」快速檢測套組可用於檢測流感和新冠病毒，15分鐘內即可在家中取得檢測結果。該產品配有虛擬指南和應用程式，方便用戶完成檢測流程並查看結果。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢與展望
  • 市場動態
  • 商業環境分析
    • PESTLE分析
    • 波特五力分析
  • 新冠疫情影響分析

第4章 技術業務分析

  • 快速檢測市場：基於技術的波動分析，2025-2033年
  • 分子診斷
  • 免疫檢測
  • 其他

第5章：依產品進行業務分析

  • 快速檢測市場：產品特定波動分析，2025-2033年
  • 裝置
  • 消耗品
  • 其他

第6章 應用業務分析

  • 快速檢測市場：基於應用領域的波動分析，2025-2033年
  • 上呼吸道感染疾病
    • 流感病毒/副流感病毒
    • 呼吸道融合細胞病毒
    • 鏈球菌
  • 抗藥性感染疾病（例如抗甲氧西林金黃色葡萄球菌、鏈球菌等）
  • 敗血症
    • 細菌性敗血症
    • 黴菌性敗血症
    • 其他

第7章 依最終用途進行業務分析

  • 快速檢測市場：依最終用途分類的波動分析，2025-2033年
  • 醫院和診所
  • 檢查室
  • 家庭檢測和其他

第8章：按地區分類的業務分析

  • 區域市場概覽
  • 北美洲
    • 2021-2033年北美快速檢測市場
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2021-2033年歐洲快速檢測市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區快速檢測市場，2021-2033年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2021-2033年拉丁美洲快速檢測市場
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 2021-2033年中東和非洲快速檢測市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 公司分類
  • 策略藍圖
    • 獲得
    • 合夥
    • 新平台推出
    • 其他
  • 公司簡介/上市資訊
    • BD（Becton, Dickinson and Company）
    • Diasorin SPA
    • Abbott
    • Danaher Corporation
    • Thermo Fisher Scientific Inc
    • Biomerieux SA
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-4-68040-028-8

Rapid Tests Market Summary

The global rapid tests market size was estimated at USD 1.69 billion in 2025 and is projected to reach USD 3.25 billion by 2033, growing at a CAGR of 8.30% from 2026 to 2033. The growth can be attributed to the growing geriatric population, rising target disease burden, and increasing adoption of self-testing & point-of-care products.

Upper respiratory tract infections (URIs) remain extremely common worldwide, with incidence rates exceeding 162,000 per 100,000 people in recent global estimates, underscoring the need for rapid differentiation of viral versus bacterial causes in clinical practice.

Upper respiratory tract infections (URTIs) remain a major global health concern in 2025, with high incidence rates particularly in children under 5 and adults with underlying conditions. Children under 5 are the most affected group for URTIs, while 97% of pediatric RSV deaths occur in low- and middle-income countries.

Furthermore, Respiratory syncytial virus (RSV) is a highly prevalent viral infection that particularly affects infants, young children, and older adults. Globally, RSV is estimated to cause approximately 33 million acute lower respiratory tract infections annually in children under five years, with over 3 million cases requiring hospitalization. In the U.S., RSV leads to 58,000-80,000 hospitalizations and 100-300 deaths among children under five each year, as well as 60,000-160,000 hospitalizations and 6,000-10,000 deaths among adults aged 65 and older. Seasonal outbreaks typically occur in the fall and winter, significantly impacting healthcare systems and underscoring the critical need for effective diagnostic and preventive measures.

Below is a comparison of Virus detections by subtype reported to FluNet, 01 October 2017 to 30 December 2024, from countries in the Northern hemisphere, as of 07 January 2025:

The dataset plots estimated global volumes of rapid diagnostics that correspond with observed respiratory pathogen activity:

Influenza rapid test demand accounts for the largest share of total respiratory testing due to its high seasonal prevalence and broad availability of RIDTs. This results in high growth of the rapid influenza diagnostic tests market over the forecast years.

RSV rapid test demand is significant and growing, driven by pediatric and high-risk population screening.

hMPV contributes a smaller but meaningful share, especially where multiplex testing platforms incorporate hMPV targets.

Collectively, these drivers reflect how seasonal respiratory trends translate into diagnostic demand, highlighting the seasonality and pathogen-specific test utilization that underpins market expansion.

Across infectious disease surveillance and public health programs, rapid tests are increasingly playing a strategic role. Governments and health authorities in 2025 are scaling up access to rapid diagnostic kits for endemic conditions beyond COVID-19; for example, the Indian Council of Medical Research (ICMR) has advocated rapid test availability for conditions such as Hepatitis B, sickle cell anemia, and syphilis at primary health centres, aiming to improve early diagnosis in underserved areas. Meanwhile, markets for specific rapid tests, such as rapid influenza diagnostic tests (RIDTs), are projected to grow steadily as seasonal flu and respiratory illnesses persist globally. This widening scope of disease targets is expanding the application base of rapid diagnostics beyond upper respiratory infections and sepsis screening into the arenas of infectious and non-communicable diseases.

Innovation and competitive dynamics are reshaping the competitive landscape and product development trajectory. Providers are increasingly integrating advanced technologies such as AI, machine learning, and microfluidics to enhance test sensitivity, multiplexing, and ease of use, which supports broader adoption in both clinical and at-home settings. Established diagnostic players and new entrants are also influencing market growth paths: for instance, Amazon's entry into home diagnostics services across major Indian cities in mid-2025 triggered notable shifts in investor sentiment in the diagnostics sector. At the same time, large strategic moves like Abbott's planned acquisition of Exact Sciences-makers of widely used cancer and genetic tests signal diagnostic companies' push to diversify beyond traditional rapid infectious disease testing into broader screening portfolios, even as they balance quality assurance and regulatory challenges in an increasingly crowded market.

Furthermore, the introduction of mobile applications, such as cobas infinity point-of-care from Roche Diagnostics, to satisfy the requirements of the POC coordinator and aid in enhancing productivity by completing the task on the smartphone irrespective of the destination, can be expected to drive the adoption of POC molecular diagnostic products during the forecast period.

Key players have shifted their focus to commercializing home-based self-testing products in recent years, and the COVID-19 outbreak has propelled this trend. Amid government-imposed lockdowns, such products addressed clinical needs while promoting self-quarantine practices. Companies, such as Abbott, have products like BinaxNOW Card rapid test for influenza and COVID-19 that delivers results at home in 15 minutes. This product comes with a virtual guide and application to enable the testing process and display test results.

Global Rapid Tests Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 - 2033. For this report, Grand View Research has segmented the global rapid tests market report based on the product, technology, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Consumables
  • Others
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay
  • Molecular Diagnostics
  • Other technologies
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Upper respiratory tract infections
    • Influenza and Parainfluenza virus
    • Streptococcus
    • Respiratory syncytial virus
  • Antibiotic resistant infections
  • Sepsis
    • Bacterial Sepsis
    • Fungal Sepsis
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Clinics
  • Laboratories
  • At-home testing and Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates And Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Type and Product Snapshot
  • 2.3. Application and End Use Snapshot
  • 2.4. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
      • 3.3.1.1. Increasing Adoption of Self-Testing & Point-of-Care Products, And Introduction of CLIA Waived Tests
      • 3.3.1.2. Growing Geriatric Population Base
      • 3.3.1.3. Introduction of Advance Technology Enablx Ed Products
      • 3.3.1.4. Growing Prevalence of Target Diseases
    • 3.3.2. Market Restraint Analysis
      • 3.3.2.1. Presence of Ambiguous Regulatory and Reimbursement Framework for Primary Care Setting
      • 3.3.2.2. Rapid Testing Sensitivity and Accuracy
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Technology Business Analysis

  • 4.1. Rapid Tests Market: Technology Movement Analysis, 2025 & 2033
  • 4.2. Molecular Diagnostics
    • 4.2.1. Molecular Diagnostics Market, 2021 - 2033 (USD Million)
  • 4.3. Immunoassay
    • 4.3.1. Immunoassay Market, 2021 - 2033 (USD Million)
  • 4.4. Others
    • 4.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 5. Product Business Analysis

  • 5.1. Rapid Tests Market: Product Movement Analysis, 2025 & 2033
  • 5.2. Instruments
    • 5.2.1. Instruments Market, 2021 - 2033 (USD Million)
  • 5.3. Consumables
    • 5.3.1. Consumables Market, 2021 - 2033 (USD Million)
  • 5.4. Others
    • 5.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 6. Application Business Analysis

  • 6.1. Rapid Tests Market: Application Movement Analysis, 2025 & 2033
  • 6.2. Upper Respiratory Tract Infections
    • 6.2.1. Upper Respiratory Tract Infections Market, 2021 - 2033 (USD Million)
    • 6.2.2. Influenza And Parainfluenza Virus
      • 6.2.2.1. Influenza And Parainfluenza Virus Market, 2021 - 2033 (USD Million)
    • 6.2.3. Respiratory Syncytial Virus
      • 6.2.3.1. Respiratory Syncytial Virus Market, 2021 - 2033 (USD Million)
    • 6.2.4. Streptococcus
      • 6.2.4.1. Streptococcus Market, 2021 - 2033 (USD Million)
  • 6.3. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumonia, And Others)
    • 6.3.1. Antibiotic-Resistant Infections (MRSA, Streptococcus Pneumoniae, And Others) Market, 2021 - 2033 (USD Million)
  • 6.4. Sepsis
    • 6.4.1. Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.2. Bacterial Sepsis
      • 6.4.2.1. Bacterial Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.3. Fungal Sepsis
      • 6.4.3.1. Fungal Sepsis Market, 2021 - 2033 (USD Million)
    • 6.4.4. Others
      • 6.4.4.1. Others Market, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

  • 7.1. Rapid Tests Market: End Use Movement Analysis, 2025 & 2033
  • 7.2. Hospitals & Clinics
    • 7.2.1. Hospitals & Clinics Market, 2021 - 2033 (USD Million)
  • 7.3. Laboratories
    • 7.3.1. Laboratories Market, 2021 - 2033 (USD Million)
  • 7.4. At-Home Testing And Others
    • 7.4.1. At-Home Testing And Others Market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

  • 8.1. Regional Market Snapshot
  • 8.2. North America
    • 8.2.1. North America Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.2.2. Key Country Dynamics
      • 8.2.2.3. Regulatory Framework
      • 8.2.2.4. Competitive Scenario
    • 8.2.3. Canada
      • 8.2.3.1. Canada Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.3.2. Key Country Dynamics
      • 8.2.3.3. Regulatory Framework
      • 8.2.3.4. Competitive Scenario
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.2.4.2. Key Country Dynamics
      • 8.2.4.3. Regulatory Framework
      • 8.2.4.4. Competitive Scenario
  • 8.3. Europe
    • 8.3.1. Europe Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.3.2. Germany
      • 8.3.2.1. Germany Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.2.2. Key Country Dynamics
      • 8.3.2.3. Regulatory Framework
      • 8.3.2.4. Competitive Scenario
    • 8.3.3. UK
      • 8.3.3.1. UK Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.3.2. Key Country Dynamics
      • 8.3.3.3. Regulatory Framework
      • 8.3.3.4. Competitive Scenario
    • 8.3.4. France
      • 8.3.4.1. France Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.4.2. Key Country Dynamics
      • 8.3.4.3. Regulatory Framework
      • 8.3.4.4. Competitive Scenario
    • 8.3.5. Italy
      • 8.3.5.1. Italy Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.5.2. Key Country Dynamics
      • 8.3.5.3. Regulatory Framework
      • 8.3.5.4. Competitive Scenario
    • 8.3.6. Spain
      • 8.3.6.1. Spain Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.6.2. Key Country Dynamics
      • 8.3.6.3. Regulatory Framework
      • 8.3.6.4. Competitive Scenario
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.7.2. Key Country Dynamics
      • 8.3.7.3. Regulatory Framework
      • 8.3.7.4. Competitive Scenario
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.8.2. Key Country Dynamics
      • 8.3.8.3. Regulatory Framework
      • 8.3.8.4. Competitive Scenario
    • 8.3.9. Norway
      • 8.3.9.1. Norway Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.3.9.2. Key Country Dynamics
      • 8.3.9.3. Regulatory Framework
      • 8.3.9.4. Competitive Scenario
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.4.2. Japan
      • 8.4.2.1. Japan Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.2.2. Key Country Dynamics
      • 8.4.2.3. Regulatory Framework
      • 8.4.2.4. Competitive Scenario
    • 8.4.3. China
      • 8.4.3.1. China Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.3.2. Key Country Dynamics
      • 8.4.3.3. Regulatory Framework
      • 8.4.3.4. Competitive Scenario
    • 8.4.4. India
      • 8.4.4.1. India Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.4.2. Key Country Dynamics
      • 8.4.4.3. Regulatory Framework
      • 8.4.4.4. Competitive Scenario
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.5.2. Key Country Dynamics
      • 8.4.5.3. Regulatory Framework
      • 8.4.5.4. Competitive Scenario
    • 8.4.6. Australia
      • 8.4.6.1. Australia Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.6.2. Key Country Dynamics
      • 8.4.6.3. Regulatory Framework
      • 8.4.6.4. Competitive Scenario
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.4.7.2. Key Country Dynamics
      • 8.4.7.3. Regulatory Framework
      • 8.4.7.4. Competitive Scenario
  • 8.5. Latin America
    • 8.5.1. Latin America Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.5.2.2. Key Country Dynamics
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Competitive Scenario
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.5.3.2. Key Country Dynamics
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Competitive Scenario
  • 8.6. MEA
    • 8.6.1. MEA Rapid Tests Market, 2021 - 2033 (USD Million)
    • 8.6.2. South Africa
      • 8.6.2.1. South Africa Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.2.2. Key Country Dynamics
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Competitive Scenario
    • 8.6.3. Saudi Arabia
      • 8.6.3.1. Saudi Arabia Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.3.2. Key Country Dynamics
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Competitive Scenario
    • 8.6.4. UAE
      • 8.6.4.1. UAE Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.4.2. Key Country Dynamics
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Competitive Scenario
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Rapid Tests Market, 2021 - 2033 (USD Million)
      • 8.6.5.2. Key Country Dynamics
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Competitive Scenario

Chapter 9. Competitive Landscape

  • 9.1. Company Categorization
  • 9.2. Strategy Mapping
    • 9.2.1. Acquisition
    • 9.2.2. Collaborations
    • 9.2.3. New Platform Launches
    • 9.2.4. Others
  • 9.3. Company Profiles/Listing
    • 9.3.1. BD (Becton, Dickinson and Company)
      • 9.3.1.1. Company Overview
      • 9.3.1.2. Financial Performance
      • 9.3.1.3. Product Benchmarking
      • 9.3.1.4. Strategic Initiatives
    • 9.3.2. Diasorin S.P.A
      • 9.3.2.1. Company Overview
      • 9.3.2.2. Financial Performance
      • 9.3.2.3. Product Benchmarking
      • 9.3.2.4. Strategic Initiatives
    • 9.3.3. Abbott
      • 9.3.3.1. Company Overview
      • 9.3.3.2. Financial Performance
      • 9.3.3.3. Product Benchmarking
      • 9.3.3.4. Strategic Initiatives
    • 9.3.4. Danaher Corporation
      • 9.3.4.1. Company Overview
      • 9.3.4.2. Financial Performance
      • 9.3.4.3. Product Benchmarking
      • 9.3.4.4. Strategic Initiatives
    • 9.3.5. Thermo Fisher Scientific Inc
      • 9.3.5.1. Company Overview
      • 9.3.5.2. Financial Performance
      • 9.3.5.3. Product Benchmarking
      • 9.3.5.4. Strategic Initiatives
    • 9.3.6. Biomerieux SA
      • 9.3.6.1. Company Overview
      • 9.3.6.2. Financial Performance
      • 9.3.6.3. Product Benchmarking
      • 9.3.6.4. Strategic Initiatives
    • 9.3.7. F. Hoffmann-La Roche Ltd.
      • 9.3.7.1. Company Overview
      • 9.3.7.2. Financial Performance
      • 9.3.7.3. Product Benchmarking
      • 9.3.7.4. Strategic Initiatives

List of Tables

  • Table 1 List Of Secondary Sources
  • Table 2 List Of Abbreviations
  • Table 3 Global Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 4 Global Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 5 Global Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 6 Global Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 7 Global Rapid Tests Market, By Region, 2021 - 2033 (USD Million)
  • Table 8 North America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 9 North America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 10 North America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 11 North America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 12 North America OTC US Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 13 U.S. Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 14 U.S. Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 15 U.S. Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 16 U.S. Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 17 Canada Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 18 Canada Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 19 Canada Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 20 Canada Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 21 Mexico Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 22 Mexico Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 23 Mexico Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 24 Mexico Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 25 Europe Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 26 Europe Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 27 Europe Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 28 Europe Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 29 Europe Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 30 UK Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 31 UK Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 32 UK Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 33 UK Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 34 Germany Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 35 Germany Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 36 Germany Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 37 Germany Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 38 France Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 39 France Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 40 France Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 41 France Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 42 Italy Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 43 Italy Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 44 Italy Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 45 Italy Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 46 Spain Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 47 Spain Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 48 Spain Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 49 Spain Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 50 Norway Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 51 Norway Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 52 Norway Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 53 Norway Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 54 Sweden Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 55 Sweden Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 56 Sweden Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 57 Sweden Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 58 Denmark Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 59 Denmark Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 60 Denmark Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 61 Denmark Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 62 Asia Pacific Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 63 Asia Pacific Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 64 Asia Pacific Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 65 Asia Pacific Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 66 Asia Pacific Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 67 Japan Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 68 Japan Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 69 Japan Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 70 Japan Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 71 China Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 72 China Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 73 China Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 74 China Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 75 India Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 76 India Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 77 India Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 78 India Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 79 Australia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 80 Australia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 81 Australia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 82 Australia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 83 South Korea Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 84 South Korea Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 85 South Korea Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 86 South Korea Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 87 Thailand Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 88 Thailand Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 89 Thailand Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 90 Thailand Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 91 Latin America Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 92 Latin America Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 93 Latin America Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 94 Latin America Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 95 Latin America Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 96 Brazil Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 97 Brazil Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 98 Brazil Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 99 Brazil Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 100 Argentina Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 101 Argentina Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 102 Argentina Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 103 Argentina Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 104 Middle East Africa Rapid Tests Market, By Country, 2021 - 2033 (USD Million)
  • Table 105 Middle East Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 106 Middle East Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 107 Middle East Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 108 Middle East Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 109 South Africa Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 110 South Africa Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 111 South Africa Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 112 South Africa Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 113 Saudi Arabia Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 114 Saudi Arabia Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 115 Saudi Arabia Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 116 Saudi Arabia Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 117 UAE Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 118 UAE Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 119 UAE Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 120 UAE Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)
  • Table 121 Kuwait Rapid Tests Market, By Product, 2021 - 2033 (USD Million)
  • Table 122 Kuwait Rapid Tests Market, By Technology, 2021 - 2033 (USD Million)
  • Table 123 Kuwait Rapid Tests Market, By Application, 2021 - 2033 (USD Million)
  • Table 124 Kuwait Rapid Tests Market, By End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market Research Process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Market Segmentation
  • Fig. 8 Market Snapshot, 2025
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration & Growth Prospect Mapping, 2025
  • Fig. 15 Global Rapid Tests Market: Type Movement Analysis
  • Fig. 16 Instruments market, 2021 - 2033 (USD Million)
  • Fig. 17 Consumables market, 2021 - 2033 (USD Million)
  • Fig. 18 Others market, 2021 - 2033 (USD Million)
  • Fig. 19 Rapid testing technology outlook: Key takeaways
  • Fig. 20 Rapid testing market: Technology movement analysis (USD Million)
  • Fig. 21 Molecular diagnostics market, 2021 - 2033 (USD Million)
  • Fig. 22 Immunoassay market, 2021 - 2033 (USD Million)
  • Fig. 23 Others market, 2021 - 2033 (USD Million)
  • Fig. 24 Rapid testing application outlook: Key takeaways
  • Fig. 25 Rapid testing market: Application type movement analysis (USD Million)
  • Fig. 26 Upper respiratory tract infections market, 2021 - 2033 (USD Million)
  • Fig. 27 Influenza and parainfluenza virus market, 2021 - 2033 (USD Million)
  • Fig. 28 Respiratory syncytial virus market, 2021 - 2033 (USD Million)
  • Fig. 29 Streptococcus market, 2021 - 2033 (USD Million)
  • Fig. 30 Antibiotic-resistant infections (MRSA, Streptococcus pneumonia, and others) market, 2021 - 2033 (USD Million)
  • Fig. 31 Sepsis market, 2021 - 2033 (USD Million)
  • Fig. 32 Bacterial Sepsis market, 2021 - 2033 (USD Million)
  • Fig. 33 Fungal sepsis market, 2021 - 2033 (USD Million)
  • Fig. 34 Others market, 2021 - 2033 (USD Million)
  • Fig. 35 Rapid testing End Use outlook: Key takeaways
  • Fig. 36 Rapid testing market: End Use movement analysis (USD Million)
  • Fig. 37 Hospitals & clinics market, 2021 - 2033 (USD Million)
  • Fig. 38 Laboratories market, 2021 - 2033 (USD Million)
  • Fig. 39 At-home testing and others market, 2021 - 2033 (USD Million)
  • Fig. 40 Global Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Regional Marketplace: Key Takeaways
  • Fig. 42 Regional Outlook, 2025 & 2033
  • Fig. 43 Global Rapid Tests Market: Regional Movement Analysis
  • Fig. 44 North America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 US Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 Canada Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Mexico Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Europe Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Germany Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 UK Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 France Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Italy Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Spain Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Denmark Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Sweden Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Norway Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Asia Pacific Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Japan Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 India Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Australia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 South Korea Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Thailand Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Brazil Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 66 Argentina Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Middle East And Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 68 South Africa Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Saudi Arabia Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 UAE Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Kuwait Rapid Tests Market Estimates and Forecasts, 2021 - 2033 (USD Million)